Covis Pharma B.V. Sustainability Profile
Covis Pharma B.V., headquartered in the Netherlands, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative therapies for patients with respiratory and cardiovascular conditions. Founded in 2015, Covis Pharma has rapidly established itself as a trusted provider of essential medications, focusing on areas such as asthma, chronic obstructive pulmonary disease (COPD), and hypertension. With a commitment to improving patient outcomes, Covis Pharma offers a range of unique products that address unmet medical needs. The company’s strategic approach to drug development and its robust portfolio have positioned it as a key competitor in the global market. Notable achievements include successful partnerships and a growing presence in major operational regions across Europe and North America, reinforcing its dedication to enhancing healthcare solutions worldwide.
DitchCarbon Score
How does Covis Pharma B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Covis Pharma B.V.'s score of 9 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Covis Pharma B.V.'s reported carbon emissions
Covis Pharma B.V., headquartered in the Netherlands (NL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Covis Pharma may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Covis Pharma, it is unclear how the company is addressing its environmental impact or contributing to broader industry efforts in climate change mitigation.
How Carbon Intensive is Covis Pharma B.V.'s Industry?
How Carbon Intensive is Covis Pharma B.V.'s Location?
Covis Pharma B.V.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Covis Pharma B.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
